Business Wire

Toshiba Wins Better Buys 2017 Innovative Product of the Year Award

15.3.2017 05:30 | Business Wire

Del

Toshiba Tec Corporation (TOKYO: 6588) announced its latest trio of color e-STUDIO multifunction printers (MFPs) have earned Better Buys 2017 Innovative Product of the Year Award. Toshiba's e-STUDIO7506AC series' premier hardware, software and exceptional value impressed the leading independent authority on office equipment during side-by-side comparisons with other manufacturers' high-volume MFPs.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170314005041/en/

“Toshiba continuously upgrades its devices with newer and better features and the e-STUDIO7506AC is no exception," said Better Buys editor Melissa Pardo-Bunte. "With their products' variety of paper-handling features, strong security and other features, Toshiba's powerful devices improve workflow within virtually any environment."

Better Buys staff was particularly impressed by the MFPs' powerful multi-core Intel® Atom processor, customizable 9-inch tablet-style user interface (UI), Embedded Application Platform (EAP) and Dual-Scan Document Feeder (DSDF).

The e-STUDIO7506AC series' (featuring the e-STUDIO7506AC, e-STUDIO6506AC and e-STUDIO5506AC models) is designed to connect, integrate and simplify the workplace while enabling users to more efficiently manage document intensive business processes. The inclusion of Intel's Atom processor simplifies complex projects. Moreover, the EAP enables the MFPs to integrate embedded or third-party applications allowing mobile users the flexibility to save and retrieve any content via the cloud.

"We are proud that our latest colour MFP has been chosen as Better Buys’ Innovative Product of the Year 2017," commented Isao Sugehara, Chief Marketing Executive of Toshiba Tec Printing Solutions Business Group. "We stand with our customer and always try to enhance their work environment. This award proved that e-STUDIO7506AC series is the innovative product, which enables us to contribute to our customer."

Toshiba's e-STUDIO7506AC series recently won Better Buys Q3 2016 Editor's Choice Award. Toshiba has earned the organization's Innovative Product of the Year Awards four out of the last five years.

About Better Buys

After more than 20 years as a trusted authority on office equipment, Better Buys is now a rebranded site that offers resources to help companies in the market for Business Intelligence solutions, HR Software, CMMS Systems, as well as printers, copiers, and scanners. Leveraging an experienced team of in-house editors, Better Buys offers a range of content and resources designed to help organizations make smarter purchasing decisions, including expert reviews, authoritative whitepapers & reports, insightful market research, comprehensive buyer’s guides, and more. For more information, visit betterbuys.com.

About Toshiba Tec

Toshiba Tec Corporation is a Toshiba’s group company, a leading provider of technology solutions, operating across multiple industries – ranging from retail, education and business services to hospitality and manufacturing. With headquarters in Japan and over 80 subsidiaries worldwide, Toshiba Tec Corporation helps organizations transform the way they create, record, share, manage and display information.

Please visit http://www.toshibatec.co.jp/en/
For Global site please visit http://www.toshibatec.com/global/

Unless otherwise specified and/or credited all images, artwork, text and graphics, logos and logotypes are the copyright and/or trademark of the respective owners. All rights reserved.

Contact information

Media Contact
Toshiba Tec Corporation
Toshihiko “Tommy” Minato, +81-(0)50-3681-5528
Marketing Department
Products, Marketing & Service Division
Printing Solutions Business Group
Toshihiko_Minato@toshibatec.co.jp

Om Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Følg saker fra Business Wire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Business Wire

IFF to Present at the Barclays Global Consumer Staples Conference21.8.2017 20:15Pressemelding

Regulatory News: International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF), a leading innovator of sensory experiences that move the world, today announced that Andreas Fibig, Chairman and Chief Executive Officer will present at the Barclays Global Consumer Staples Conference in Boston, MA on Thursday, September 7, 2017 at 11:15 a.m. EDT. Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay. Meet IFF International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris:IFF) is a leading innovator of sensorial experiences that move the world. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for explorati

Celularity, Inc., Accelerates Breakthrough Placental Discovery & Therapeutic Platform21.8.2017 20:11Pressemelding

Celularity, Inc., a newly formed biotechnology company, today announced its acceleration of cell and tissue regenerative therapies to address unmet medical needs in cancer and chronic and degenerative disease. Celularity completed their Series A financing with contributions from several biopharma companies, including Sorrento Therapeutics, United Therapeutics Corporation and Human Longevity, Inc., and entrepreneurial investors. Celularity has been created through the contributions of extensive intellectual property, clinical-stage assets, basic and clinical research, and development expertise including: Several clinical-stage immuno-oncology and regenerative medicine assets and a pipeline of pre-clinical assets Proprietary allogeneic (“readily accessible”) immunotherapy platform 200+ issued and pending patents in cell therapy

European Commission Grants New Indication for Soliris® (Eculizumab) for the Treatment of Patients with Refractory Generalized Myasthenia Gravis (gMG)21.8.2017 13:25Pressemelding

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) announced today that the European Commission (EC) approved the extension of the indication for Soliris® (eculizumab) to include the treatment of refractory generalized myasthenia gravis (gMG) in adults who are anti-acetylcholine receptor (AChR) antibody-positive. Soliris is the first and only complement-based therapy approved in the European Union (EU) for this ultra-rare subset of patients.1-4 Patients with refractory gMG can have difficulties walking, talking, swallowing and breathing normally despite therapies currently used for MG. Exacerbations and crises of their disease may require hospitalization and intensive care and may be life-threatening.5-7 Soliris will be launched for this new indication initially in Germany, and Alexion is evaluating launches in additional EU countries. “Patients with refractory gMG have exhausted multiple the

IntegenX Applauds the Passage of the Rapid DNA Act of 201721.8.2017 12:00Pressemelding

IntegenX Inc., the global market leader for Rapid DNA human identification, applauds the signing into law of S.139 and HR.510, The Rapid DNA Act of 2017. The legislation will allow law enforcement agencies, under standards and guidelines established by the FBI, to perform real-time DNA testing at time of arrest, within booking stations. Similar to how fingerprint analysis has evolved from a paper and ink practice to a point-of-action technology, DNA testing has now become possible in 90 minutes within a booking station, while a suspect is still in custody. With processing times reduced from weeks to less than two hours, the potential to identify or exonerate a suspect quickly will make a meaningful impact on law enforcement. IntegenX thanks U.S. Senate sponsor Senator Orrin Hatch (R-UT) and lead co-sponsor Senator Dianne Feinstein (D-CA) as well as House sponsor Congressman

PPG Completes COLORFUL COMMUNITIES Project at Primary School in Kecskemét, Hungary21.8.2017 08:03Pressemelding

PPG (NYSE:PPG) today announced the completion of a COLORFUL COMMUNITIES™ project in Kecskemét, Hungary, that helped revitalize the learning environment of the Corvin Mátyás primary school. The Colorful Communities program provides PPG volunteers and products along with financial contributions to bring color and vitality to communities where the company operates around the world, such as in Kecskemét, where the PPG automotive service team operates with 33 employees. The project brought together more than 140 PPG and community volunteers who spent three days at the school revitalizing four classrooms, four changing rooms and the playground. PPG provided more than $20,000 to assist with the project, including more than 460 liters of Héra ® Prémium waterborne interior paint and Trinát ® Aqua wate

Glennmont Partners Completes Refinancing of Sleaford Biomass Plant for £150m21.8.2017 08:00Pressemelding

Glennmont Partners has successfully completed the refinancing of the Sleaford Renewable Energy Plant on behalf of its dedicated clean energy fund, Glennmont Clean Energy Fund Europe I, as part of a programme of realisations of value from the Fund. Glennmont Partners is one of Europe’s largest fund managers focusing exclusively on investment in clean energy infrastructure. Glennmont raises long-term capital to invest in alternative power generation projects including wind farms, biomass power stations, solar parks and small-scale hydro power plants. The carefully selected, risk managed investments deliver sustained performance and predictable returns over periods of 10 years or more. Sleaford REP is a 40MWe straw-fired biomass plant located in Lincolnshire, UK. The plant has been in operation since 2014 and is being operated by Burmeister & Wain Scandinavian Contractor (BWSC). The

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom